Stock 9995 REMEGEN CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus RemeGen Co., Ltd.

Equities

9995

CNE1000048G6

Delayed Hong Kong S.E.
Other stock markets
 11:59:38 2024-04-24 pm EDT 		5-day change 1st Jan Change
31.45 HKD +6.97% Intraday chart for RemeGen Co., Ltd. +15.20% -16.02%
Apr. 04 Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication MT
Apr. 02 Remegen Co., Ltd. Announces FDA Grants Telitacicept Fast Track designation for Treatment of pSS CI

Evolution of the average Target Price on RemeGen Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

27c4.4-o_D7XWuJGhyWfqOhwKg_KPXCLfQtPS2F7liCDt7IA.hr15VeLg6sT4uVavUytm6rHmCWaRK5yA9Wa150OCuumSoklFzZ7-pNSvFA~82a883999c473c03e043988fb7a51e0b

Analyst Recommendations on RemeGen Co., Ltd.

UBS Adjusts RemeGen's Price Target to HK$75.20 From HK$75.03, Keeps at Buy MT
UBS Upgrades RemeGen to Buy From Neutral, Adjusts Price Target to HK$75.03 From HK$108 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
27.2 CNY
Average target price
39.92 CNY
Spread / Average Target
+46.78%
High Price Target
58.12 CNY
Spread / Highest target
+113.71%
Low Price Target
25.86 CNY
Spread / Lowest Target
-4.93%

Consensus detail

Consensus revision (last 18 months)

Analysts covering RemeGen Co., Ltd.

UBS

Ratings for RemeGen Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 9995 Stock
  4. Consensus RemeGen Co., Ltd.